Monika Tornsen
Director/Board Member en IMMUNIC, INC. .
Perfil
Monika Maria Tornsen is an Independent Director at Immunic, Inc. and President-North America at Calliditas Therapeutics AB.
She was previously Senior Vice President & General Manager-US at Sarepta Therapeutics, Inc., Vice President-Global Therapeutic at Genzyme Corp., and Chief Commercial Officer at Passage Bio, Inc. Tornsen is a graduate of the University of Lund.
Cargos activos de Monika Tornsen
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNIC, INC. | Director/Board Member | 05/07/2022 |
| CALLIDITAS THERAPEUTICS AB | Corporate Officer/Principal | 07/01/2024 |
Antiguos cargos conocidos de Monika Tornsen.
| Empresas | Cargo | Fin |
|---|---|---|
| PASSAGE BIO, INC. | Corporate Officer/Principal | 01/12/2022 |
| SAREPTA THERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2021 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2019 |
Formación de Monika Tornsen.
| University of Lund | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| SAREPTA THERAPEUTICS, INC. | Health Technology |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| PASSAGE BIO, INC. | Health Technology |
| IMMUNIC, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Monika Tornsen
